Condition
Osteomyelitis - Foot
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06628115Not ApplicableCompletedPrimary
Post Market Study of Cerament V/G in Pedal Osteomyelitis
NCT07266753Phase 4Recruiting
Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot
NCT05074147Phase 3WithdrawnPrimary
Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)
NCT06388603Not ApplicableRecruitingPrimary
RCT on Bioactive Glass S53P4 in Diabetic Foot Osteomyelitis in the Forefoot (DFORCT)
NCT06262854Not ApplicableNot Yet Recruiting
Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study
Showing all 5 trials